APVO vs CLOV · rev $3.1M vs rev $1.37B
Aptevo Therapeutics Inc (APVO) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Aptevo Therapeutics Inc (APVO) is a biotechnology company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported APVO revenue for 2022-12-31 was $3.1M. Net income was $8.0M. APVO currently screens at market cap $9.9M.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
APVO currently screens at market cap $9.9M. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the APVO and CLOV stock pages for the full models.
Not investment advice.